Skip to main content
. 2014 Aug 26;9(8):e103983. doi: 10.1371/journal.pone.0103983

Figure 2. Bland-Altman model showing the agreement between (A) NucliSens v2.0 and CAP/CTM v2.0 (B) NucliSens v2.0 and Amplicor v1.5 (C) CAP/CTM v2.0 and Amplicor v1.5.

Figure 2

Dashed horizontal lines show the mean difference and the dotted lines indicate the 95% limits of agreement.